Cell therapy startup Myeloid narrows focus as staff shrinks

Myeloid Therapeutics, a company developing in vivo cell therapies for cancer as well as a novel gene editing technology, has restructured to focus on its two clinical-stage programs, the company's CEO confirmed to Endpoints News ...

Apr 15, 2025 - 03:28
 0
Cell therapy startup Myeloid narrows focus as staff shrinks
Myeloid Therapeutics, a company developing in vivo cell therapies for cancer as well as a novel gene editing technology, has restructured to focus on its two clinical-stage programs, the company's CEO confirmed to Endpoints News ...